Notice of Full-Year Results
19 September 2018
Volution Group plc
Notice of Results
Volution Group plc (LSE: FAN), a leading supplier of ventilation products to the residential and commercial construction markets, will announce its final results for the year ended 31 July 2018 at 7.00am on Thursday 11 October 2018.
A meeting for analysts will be held at 9.30am on the day at the offices of Tulchan Communications, 85 Fleet Street, London EC4Y 1AE. Please contact [email protected] to register to attend or for instructions on how to connect to the meeting via conference facility.
-Ends-
For further information:
Enquiries:
|
|
Volution Group plc |
|
Ronnie George, Chief Executive Officer | +44 (0) 1293 441501 |
Ian Dew, Chief Financial Officer | +44 (0) 1293 441536 |
|
|
Tulchan Communications | +44 (0) 207 353 4200 |
James Macey White |
|
David Ison |
|
Legal Entity Identifier: 213800EPT84EQCDHO768.
Note to Editors:
Volution Group plc (LSE: FAN) is a leading supplier of ventilation products to the residential and commercial construction markets in the UK, the Nordics, Central Europe and Australasia.
The Volution Group operates through two divisions: the Ventilation Group and the OEM (Torin-Sifan) division. The Ventilation Group consists of 16 key brands - Vent-Axia, Manrose, Diffusion, National Ventilation, Airtech, Breathing Buildings, Fresh, PAX, VoltAir, Welair, Kair, Pilpit, Air Connection, inVENTer, Ventilair and Simx focused primarily on the UK, the Nordic, Central European and Australasian ventilation markets. The Ventilation Group principally supplies ventilation products for residential and commercial ventilation applications. The OEM (Torin-Sifan) division supplies motors, fans and blowers to OEMs of heating and ventilation products for both residential and commercial construction applications in Europe.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.